Mid-Morning Look
Tuesday, September 01, 2020
Index |
Up/Down |
% |
Last |
|
||
DJ Industrials |
79.13 |
0.28% |
28,509 |
|||
S&P 500 |
13.83 |
0.40% |
3,514 |
|||
Nasdaq |
119.63 |
1.02% |
11,896 |
|||
Russell 2000 |
5.86 |
0.37% |
1,567 |
|||
Economic Data
· July construction spending rises +0.1% vs. est. 1% and compared to June down (-0.5%); private construction spending rose 0.6% and public spending down (-1.3%)
· ISM manufacturing activity index rises to 56.0 in August (highest since January 2019), topping the consensus for 54.5 reading and was above the 54.2 reading in July; prices paid index 59.5 vs. 53.2 in July, new orders index jumped to 67.6 (highest since December 2017) from 61.5 in July and the employment index 46.4 topped 44.3 in July
Macro |
Up/Down |
Last |
|
||
WTI Crude |
0.62 |
43.23 |
|||
Brent |
0.75 |
46.03 |
|||
Gold |
0.40 |
1,979.00 |
|||
EUR/USD |
0.0007 |
1.1944 |
|||
JPY/USD |
0.22 |
106.12 |
|||
10-Year Note |
0.013 |
0.717% |
|||
Sector Movers Today
· Gaming sector; PENN rebounds after Craig Hallum said the sports betting and online gaming (i.e. blackjack, roulette, slots) market is less than $2B today but is expected to grow to $20B+ over the next decade as initiates with buy and $75 tgt but sees potential to $200 plus; Bloomberg reported that William Hill eyes CZR’s online gaming after completing purchase of CG Technology which was spun off from Cantor https://bloom.bg/3i0gjti ; WYNN, MLCO, MGM active after gaming revenue in Macau fell 94.5% in February to 1.33B patacas ($167M), with the relaxation of travel and visa restrictions in some regions only leading to a minor bump of traffic months end
· Biotech movers; GILD announced an agreement with JNCE to exclusively license its JTX-1811 program (GILD to make $85M upfront payment and $35M equity investment); PSTV said the FDA grants orphan drug designation for its lead investigational drug, Rhenium NanoLiposomes; for treatment of patients with recurrent glioblastoma, an aggressive type of brain cancer; ORTX says additional interim data from clinical trial evaluating safety and efficacy of OTL-203 for treatment of mucopolysaccharidosis type I support planned initiation of registrational trial in 2021
· Retailers; WMT unveils perks of its new membership program, Walmart Plus, which will grant subscribers unlimited free delivery, fuel discounts and no checkout lines as the new loyalty program will cost $98 a year, or $12.95 a month, slightly cheaper than AMZN Prime membership; BBW shares rise after earnings as Q2 E-commerce sales jump near four-fold, helping beat Wall Street revenue estimates and said have seen (Q3) sales trends steadily improve in store locations; JILL has just 10 days to get permission from the vast majority of its lenders for a deal that would extend the struggling retailer’s debt maturities, excuse it from financial covenants and give it fresh cash
· Hardware & Component news; AAPL rises again early following its recent 4 for 1 stock split, as well as reports (from Bloomberg) that it has asked suppliers to build at least 75 million 5G iPhones for later this year, roughly the same as last year; NPTN was upgraded at B Riley to buy based on Huawei being de-risked while demand from non-Huawei customers remains strong, following the company’s Q3 update reaffirming views; RXT reports higher revenue, as Q2 bookings rise 107% to $288M and issues a better forecast for 2020 profit
Stock GAINERS
· ATNX +12%; as the FDA grants priority review to Athenex’s marketing application for its oral metastatic breast cancer treatment
· COHU +5%; said it now expects Q3 revenue at high-end of guidance at approximately $146M (est. $140.4M) as order forecast has improved through Q3
· JNCE +62%; as GILD announced an agreement with the co to exclusively license its JTX-1811 program (GILD to make $85M upfront payment and $35M equity investment)
· KODK +40%; after D.E. Shaw reports 5.2% stake as of Aug. 21 in a 13G filing
· LBRT +43%; as SLB said it is selling its North America fracking business to rival Liberty Oilfield Services Inc. for a 37% stake in a new combined company,
· QCOM +1%; upgraded to Equal Weight at Wells and boosted tgt to $120 from $90 based on higher peer group valuation metrics as well as various possible outcomes to the Huawei situation
· WMT +2%; unveils perks of its new membership program, Walmart Plus, which will grant subscribers unlimited free delivery, fuel discounts and no checkout lines as the new loyalty program will cost $98 a year, or $12.95 a month
· ZM +36%; after another historic quarter in F2Q21, with revenue at $664M (+355% y/y) vs. consensus at $500M and billings at $854M (+384% y/y) vs. consensus at $553M and 32% q/q and raised its yearly profit and revenue outlook
Stock LAGGARDS
· ABBV -2%; after U.S. house oversight panel subpoena seeks documents from AbbVie from 2009 through 2019 regarding Humira, Imbruvica
· KHC -2%; as defensive food stocks underperform with broader markets higher – CPB, K also slip)
· REGN -3%; as it and SNY said that the rheumatoid arthritis drug Kevzara failed a Phase 3 clinical trial testing the therapy as a treatment for severely ill COVID-19 patients.
· TSLA -1%; after the company entered into an agreement with a syndicate of banks to sell up to $5.0B of its shares over time
Market commentary provided by Catena Media Financials US, LLC, a firm separate from and not affiliated with Regal Securities. Regal Securities has not participated in the creation of the content, and does not explicitly or implicitly endorse the content.